| Bioactivity | UR-2922 is a platelet GPIIb/IIIa antagonist with antiplatelet aggregation and cardiovascular disease inhibition activities. UR-2922 has high affinity for human platelet receptors and has good pharmacokinetic properties, and can be used to inhibit cardiovascular diseases. |
| CAS | 220386-56-1 |
| Formula | C25H25N7O6 |
| Molar Mass | 519.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. UR-3216: a new generation oral platelet GPIIb/IIIa antagonist |
UR-2922
CAS: 220386-56-1 F: C25H25N7O6 W: 519.51
UR-2922 is a platelet GPIIb/IIIa antagonist with antiplatelet aggregation and cardiovascular disease inhibition activiti
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.